Source:http://linkedlifedata.com/resource/pubmed/id/12581740
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-2-12
|
pubmed:abstractText |
Lysosomal cysteine proteinase cathepsin B is implicated in remodeling the extracellular matrix, a crucial step in the process of tumor cell invasion. In this study the contributions of intracellular and extracellular cathepsin B activities in the invasion of ras-transformed human breast epithelial cells, MCF-10A neoT, were assessed using specific cathepsin B neutralizing monoclonal antibody (Mab) 2A2, together with other general and specific cysteine proteinase inhibitors. We showed that the degradation of extracellular matrix by living MCF-10A neoT cells was predominantly intracellular, as imaged by confocal assays using quenched fluorescent substrate DQ-collagen IV. CA-074, a membrane-impermeable cathepsin B-selective inhibitor and its membrane-permeable analogue CA-074Me showed similar inhibition of invasion at 10 microM, i.e., 24.9 and 27.0%, respectively. Neutralizing monoclonal antibody exhibited a significantly higher inhibitory effect, decreasing invasion at 0.5 microM by 42.7%. Tumor cells may internalize monoclonal antibody; therefore, 2A2 Mab could impair both the intracellular and the extracellular fractions of cathepsin B activity. However, both 2A2 Mab and cathepsin B-selective inhibitors were less potent than the general cysteine proteinase inhibitors chicken cystatin and E-64, indicating that other cysteine proteinases, presumably cathepsin L, are involved in invasion. Our results show that intracellular and extracellular cathepsin B activity contribute to in vitro invasion of MCF-10A neoT cells and suggest that inhibitors capable of impairing both fractions have a potential as new anticancer drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-4827
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2003 Elsevier Science (USA)
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
206-14
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12581740-Antibodies, Monoclonal,
pubmed-meshheading:12581740-Antibody Affinity,
pubmed-meshheading:12581740-Antibody Specificity,
pubmed-meshheading:12581740-Breast Neoplasms,
pubmed-meshheading:12581740-Cathepsin B,
pubmed-meshheading:12581740-Cell Culture Techniques,
pubmed-meshheading:12581740-Collagen Type IV,
pubmed-meshheading:12581740-Cysteine Proteinase Inhibitors,
pubmed-meshheading:12581740-Extracellular Matrix,
pubmed-meshheading:12581740-Female,
pubmed-meshheading:12581740-Humans,
pubmed-meshheading:12581740-Hybridomas,
pubmed-meshheading:12581740-Immunohistochemistry,
pubmed-meshheading:12581740-Neoplasm Invasiveness,
pubmed-meshheading:12581740-Tumor Cells, Cultured
|
pubmed:year |
2003
|
pubmed:articleTitle |
Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. ales.premzl@ijs.si
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|